Latest Artificial Intelligence News

Loyal Metals has intersected 60 metres of rich chalcocite copper mineralisation near the surface at its Highway Reward Project, confirming the presence of extensive copper-gold deposits and advancing exploration efforts with a third drill underway.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.

4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.

Tivan Limited has restarted fieldwork at its Sandover AI Project in central Australia, leveraging AI-driven targeting alongside enhanced collaboration with EARTH AI. Results from new electromagnetic surveys are expected by March 2026, setting the stage for expanded drilling campaigns.

Argenica Therapeutics’ AI-powered reanalysis of its Phase 2 trial reveals significant efficacy of ARG-007 in severe acute ischemic stroke patients, highlighting improved functional outcomes and reduced brain damage.

SenSen Networks reports robust Q2 FY26 revenue momentum, driven by five new city wins in North America, a surge in variable licence fees in Australia, and expanded fuel retail site deployments.

Nanoveu’s subsidiary EMASS has teamed up with Semtech to integrate ultra-low-power AI with long-range LoRa connectivity, promising smarter, battery-efficient IoT devices for industrial and smart city applications.

DigiCo Infrastructure REIT appoints Michael Juniper as CEO, signaling a strategic push into advanced data centre development amid rising cloud and AI demand. Chris Maher shifts focus to government relations, underscoring regulatory challenges ahead.

Algorae Pharmaceuticals has independently validated its AI-driven drug combination platform, AlgoraeOS v1, confirming its ability to predict synergistic cancer drug pairs. The company has also launched an upgraded version, AlgoraeOS v2, poised to enhance drug discovery efforts.

NEXTDC has inked a Memorandum of Understanding with OpenAI to develop a cutting-edge sovereign AI infrastructure in Sydney, marking a major step in Australia’s digital sovereignty ambitions.

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

BrainChip Holdings has closed its Share Purchase Plan with subscriptions exceeding the $2 million target by nearly $1 million, complementing a recent $35 million placement. The Board’s decision to accept all applications reflects robust shareholder confidence.